Position history for Orbis Allan Gray Ltd's holdings in ALNYLAM PHARMACEUTICALS INC
Orbis Allan Gray Ltd holds 1.3M shares of ALNY (ALNYLAM PHARMACEUTICALS INC), worth $441.7M as of 2026-Q1. The position was decreased (-17.5% shares). ALNY represents 1.9% of Orbis Allan Gray Ltd's portfolio.
Current Value
$441.7M
Current Shares
1.3M
Total Value Change
+$266.4M
Total Shares Change
+613,772
Other major holders of ALNY: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 1.3M |
-17.5% |
| $441.7M |
| 1.9% |
| $318.65 |
0 |
| 2025-Q4 | Decreased | 1.6M | -17.1% | $643.5M | 2.7% | $397.25 | 0 |
| 2025-Q3 | Decreased | 2M | -8.0% | $889.6M | 3.8% | $447.49 | 0 |
| 2025-Q2 | Increased | 2.1M | +29.8% | $691.8M | 3.4% | $322.83 | 73 |
| 2025-Q1 | Increased | 1.6M | +11.0% | $441.5M | 2.5% | $268.46 | 59 |
| 2024-Q4 | Increased | 1.5M | +16.1% | $346.6M | 1.9% | $236.01 | 57 |
| 2024-Q3 | Increased | 1.3M | +75.9% | $348.8M | 1.8% | $274.91 | 74 |
| 2024-Q2 | New | 721,053 | - | $175.2M | 1.1% | $243.00 | 70 |